MIRA INFORM REPORT

 

 

Report No. :

315606

Report Date :

02.04.2015

 

IDENTIFICATION DETAILS

 

Name :

VIRCHOW BIOTECH PRIVATE LIMITED

 

 

Registered Office :

Plot No. 4, SV Co-Operative Industrial Estate, IDA, Jeedimetla, Hyderabad – 500 005, Telangana

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

04.04.2001

 

 

Com. Reg. No.:

36-036520

 

 

Capital Investment / Paid-up Capital :

Rs. 170.331 Million

 

 

CIN No.:

[Company Identification No.]

U24210TG2001PTC036520

 

 

TIN No.:

36520293990

 

 

C S T No.:

HYR/03/1/4162/01-02

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

Not Available

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharmaceutical Products.

 

 

No. of Employees :

Information declined by the management

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (46)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 1400000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track record.

 

Financial position of the company seems to be decent.

 

Trade relations are reported as fair. Business is active. Payments terms are reported to be usually correct.

 

The company can be considered good for normal business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

 

Rating Agency Name

Not Available

Rating

Not Available

Rating Explanation

Not Available

Date

Not Available

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

INFORMATION PARTED BY (PARTIAL DETAILS)

 

Name :

Mr. Naresh

Designation :

Personal Secretary

Contact No.:

91-40-23119481

Date :

01.04.2015

 

 

LOCATIONS

 

 

Registered Office :

Plot No. 4, SV Co-Operative Industrial Estate, IDA, Jeedimetla, Hyderabad – 500 005, Telangana, India

Tel. No.:

91-40-65452205 / 23096688 / 23098206 / 23800924/23119481

Fax No.:

91-40-23096677 / 23098205

E-Mail :

info@virchows.com

accvbpl@rediffmail.com

virchowbiotech2001@gmail.com

Website :

http://virchows.com

http://virchowbiotech.com/

 

 

 

Sy No 172, Part Gagillapur (V), Qutubullapur(M,) Ranga Reddy, Hyderabad, Telangana, India

 

 

Marketing Office:

Plot No. 319 and 320, 3rd Floor, Swamy Ayyappa Co-Operative Housing Society, Madhapur, Hyderabad – 500081, Telangana, India

Tel. No.:

91-40-23119481/65894168

Fax No.:

91-40-23119486

E-Mail :

Finance@virchowonline.com 

 

 

DIRECTORS

 

As on 27.09.2014

 

Name :

Mr. Tummuru Muralikrishna Reddy

Designation :

Whole-time director

Address :

Plot No.321/A26, Road No. 25, Jubilee Hills, Hyderabad – 500055, Telangana, India

Date of Birth/Age :

05.01.1960

Date of Appointment :

01.04.2013

DIN No.:

02469013

Pan No.:

AEVPT6906K

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24210TG2001PTC036520

VIRCHOW BIOTECH PRIVATE LIMITED

Whole-time director

01-04-13

22-11-01

-

Active

NO

 

 

Name :

Mr. Hemanth Nandigala

Designation :

Director

Address :

Plot No. 550, Road No. 19, Jubilee Hills, Hyderabad – 500 055, Telangana, India

Date of Birth/Age :

02.01.1974

Date of Appointment :

04.04.2001

DIN No.:

01561731

Pan No.:

ACAPN0908Q

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24232TG1982PLC003368

VIRCHOW LABORATORES LIMITED.

Director

29-01-99

29-01-99

-

Active

NO

2

U24210TG2001PTC036520

VIRCHOW BIOTECH PRIVATE LIMITED

Director

04-04-01

04-04-01

-

Active

NO

3

U24230MH2007PTC176048

VIRCHOW HEALTHCARE PRIVATE LIMITED

Director

20-11-07

20-11-07

-

Active

NO

4

U65910TG1988PTC008596

VIRCHOW CHEMICALS PVT. LTD.

Director

30-09-11

01-04-11

-

Active

NO

5

U85195TG1988PLC008172

SARACA LABORATORIES LIMITED

Additional director

04-11-14

04-11-14

-

Active

NO

 

 

Name :

Mr. Nandigala Venkata Reddy

Designation :

Director

Address :

No. 550, Road No. 19, Jubilee Hills, Hyderabad – 500 033, Telangana, India

Date of Birth/Age :

01.07.1943

Date of Appointment :

04.04.2001

DIN No.:

01740424

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U65910TG1980PTC002612

NANDINI FINANCE PVT LTD

Director

10-11-86

10-11-86

01-04-13

Active

NO

2

U65910TG1985PTC005769

LVSR LEASING AND FINANCE PRIVATE LIMITED

Director

05-08-87

05-08-87

-

Active

NO

3

U24232TG1982PLC003368

VIRCHOW LABORATORES LIMITED.

Managing director

01-06-11

30-09-96

-

Active

NO

4

U24210TG2001PTC036520

VIRCHOW BIOTECH PRIVATE LIMITED

Director

04-04-01

04-04-01

-

Active

NO

5

U74210TG1974PTC001733

IMEX ENGINEERING CO PVT LTD

Director

18-10-01

18-10-01

-

Active

NO

6

U23209TG2003PTC041101

VIRCHOW PETROCHEMICAL PRIVATE LIMITED

Director

04-06-03

04-06-03

-

Active

NO

7

U24116TG1991PLC012314

ANDHRA ORGANICS LIMITED

Director

08-09-04

08-09-04

-

Active

NO

8

U72300TG2007PTC055671

MAX INFRATECH (INDIA) PRIVATE LIMITED (PART IX)

Director

25-09-07

25-09-07

03-11-07

Amalgamated

NO

9

U24239TG2004PLC042949

VIRCHOW DRUGS LIMITED

Director

29-09-09

31-03-09

-

Active

NO

 

 

Name :

Mr. Mundla Narayana Reddy

Designation :

Director

Address :

No. 15-A, Road No. 2, Jubilee Hills, Hyderabad – 500 033, Telangana, India

Date of Birth/Age :

01.06.1951

Date of Appointment :

04.04.2001

DIN No.:

00064392

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24232TG1982PLC003368

VIRCHOW LABORATORES LIMITED.

Managing director

01-06-11

20-01-82

-

Active

NO

2

U24210TG2001PTC036520

VIRCHOW BIOTECH PRIVATE LIMITED

Director

04-04-01

04-04-01

-

Active

NO

3

U74210TG1974PTC001733

IMEX ENGINEERING CO PVT LTD

Director

18-10-01

18-10-01

-

Active

NO

4

U24230TG2002PTC039606

COVALENT LABORATORIES PRIVATE LIMITED

Director

15-05-03

15-05-03

-

Active

NO

5

U23209TG2003PTC041101

VIRCHOW PETROCHEMICAL PRIVATE LIMITED

Director

04-06-03

04-06-03

-

Active

NO

6

U24239TG2004PLC042949

VIRCHOW DRUGS LIMITED

Director

25-03-04

25-03-04

-

Active

NO

7

U24116TG1991PLC012314

ANDHRA ORGANICS LIMITED

Director

08-09-04

08-09-04

-

Active

NO

8

U24110TG2005PTC046609

EMMENNAR CHEM PRIVATE LIMITED

Director

22-06-05

22-06-05

-

Amalgamated

NO

9

U45200TG2005NPL045814

HYDERABAD PHARMA INFRASTRUCTURE AND TECHNOLOGIES

Director

21-12-06

21-12-06

17-01-11

Active

NO

10

U24230MH2007PTC176048

VIRCHOW HEALTHCARE PRIVATE LIMITED

Director

20-11-07

20-11-07

-

Active

NO

11

U24299TG2002PTC039653

EMMENNAR PHARMA PRIVATE LIMITED

Director

10-03-08

10-03-08

01-10-13

Active

NO

12

U74999TG2007PLC052432

SV'S REMEDIES LIMITED

Director

29-09-12

16-05-12

-

Amalgamated

NO

 

 

KEY EXECUTIVE

 

Name :

Mr. Naresh

Designation :

Personal Secretary

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 27.09.2014

 

Names of Shareholders

 

No. of Shares

M Sudha

 

884270

M Narayana Reddy

 

956455

M Madhu Vushnu

 

969636

M Lakshmi Prasanna

 

340759

N Venkata Reddy

 

1230039

N Hemanth

 

897641

Prasath N

 

825125

Tummuri Teena

 

113150

Murali Krishna Reddy Tummuru

 

1500724

Usha Kurre

 

842241

Rajesh R Tummuru

 

77620

Meena Tummuru

 

49212

Virchow Labs Limited, India

 

8346210

Total

 

17033082

 

Equity Share Break up (Percentage of Total Equity)

 

As on 27.09.2014

 

Category

Percentage

Bodies corporate

49.00

Directors or relatives of Directors

51.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceutical Products.

 

 

Products :

Item Code No.

Product Description

30049015

Biotech Product

 

 

Brand Names :

Not Divulged

 

 

Agencies Held :

Not Divulged

 

 

Exports :

 

Products:

Pharmaceutical Products

Country:

  • Pakistan
  • Italy

 

 

Imports :

Not Divulged

 

 

Terms :

Not Divulged

 

 

PRODUCTION STATUS NOT AVAILABLE

 


 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

Customers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

No. of Employees :

Information declined by the management

 

 

Bankers :

Bank Name

Canara Bank

Branch

Somajiguda Branch,

Hyderabad,

Andhra Pradesh, India

Person Name (With Designation)

Not Divulged

Contact Number

Not Divulged

Name of Account Holder

Not Divulged

Account Number

Not Divulged

Account Since (Date/Year of Account Opening)

Not Divulged

Average Balance Maintained (If Possible)

Not Divulged

Credit Facilities Enjoyed (If any)

Not Divulged

Account Operation

Not Divulged

Remarks (If any)

Not Divulged

 

 

Facilities :

Secured Loan

31.03.2014

(Rs. in Million)

31.03.2013

(Rs. in Million)

Long-term Borrowings

 

 

Term loans from others

81.238

99.947

Total

81.238

99.947

 

Financial institute:

  • Department of Biotechnology, Block 2, CGO Complex, Lodhi Road, New Delhi - 110003, Delhi, India
  • Technology Dev. Board, Technology Bhavan, New Mehrauli Road, New Delhi - 110016, Delhi, India

 

 

Auditors :

 

Name :

Ramana Reddy and Associates

Chartered Accountants

Address :

Unit No 406 4th, Floor Ashoka Capital Opposite Kbr Park Road, No 2 Banjara

Hills Hyderabad – 500034, Telangana, India

PAN N Income-tax PAN of auditor or auditor's firm :

AADFA6113F

 

 

Memberships :

--

 

 

Collaborators :

--

 

 

Associated Companies controlled by key management personnel / relatives who are

substantially interested:

  • Virchow Laboratories Limited, India [U24232TG1982PLC003368]
  • Virchow Health Care Private Limited, India [U24230MH2007PTC176048]

 

 

CAPITAL STRUCTURE

 

As on 31.03.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

20500000

Equity Shares

Rs.10/- each

Rs. 205.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

17033082

Equity Shares

Rs.10/- each

Rs. 170.331 Million

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2014

31.03.2013

31.03.2012

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

170.331

151.391

151.391

(b) Reserves & Surplus

308.243

178.405

101.768

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

478.574

329.796

253.159

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

115.583

142.259

153.734

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

115.583

142.259

153.734

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

10.406

4.630

6.982

(c) Other current liabilities

73.746

70.283

69.911

(d) Short-term provisions

25.478

17.621

14.026

Total Current Liabilities (4)

109.630

92.534

90.919

 

 

 

 

TOTAL

703.787

564.589

497.812

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

418.891

321.153

222.318

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

8.467

21.767

10.311

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

49.133

46.379

39.930

(d)  Long-term Loan and Advances

24.501

14.194

72.369

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

500.992

403.493

344.928

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

24.965

20.888

16.100

(c) Trade receivables

60.351

54.158

18.461

(d) Cash and cash equivalents

80.083

49.158

99.769

(e) Short-term loans and advances

31.348

26.426

14.637

(f) Other current assets

6.048

10.466

3.917

Total Current Assets

202.795

161.096

152.884

 

 

 

 

TOTAL

703.787

564.589

497.812

 

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

Turnover

395.341

270.333

268.883

 

Other Income

NA

NA

NA

 

TOTAL

NA

NA

NA

 

 

 

 

 

Less

EXPENSES

NA

NA

NA

 

 

 

 

 

Less

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

158.799

108.066

86.463

 

 

 

 

 

Less

FINANCIAL EXPENSES

3.579

4.084

5.395

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

155.220

103.982

81.068

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

33.719

16.172

12.924

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

121.501

87.810

68.144

 

 

 

 

 

Less

TAX

22.724

11.172

10.701

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX 

98.777

76.638

57.443

 

 

 

 

 

 

IMPORTS

 

 

 

 

Raw Materials

2.711

1.743

NA

 

Capital Goods

15.242

11.092

NA

 

TOTAL IMPORTS

17.953

12.835

NA

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

6.52

5.06

NA

 

 


KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Return on Total Assets

(PBT/Total Assets}

(%)

18.80

17.69

15.23

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.25

0.27

0.27

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.24

0.43

0.61

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.85

1.74

1.68

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

151.391

151.391

170.331

Reserves & Surplus

101.768

178.405

308.243

Net worth

253.159

329.796

478.574

 

 

 

 

long-term borrowings

153.734

142.259

115.583

Short term borrowings

0.000

0.000

0.000

Total borrowings

153.734

142.259

115.583

Debt/Equity ratio

0.607

0.431

0.242

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Turnover

268.883

270.333

395.341

 

 

0.539

46.242

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Turnover

268.883

270.333

395.341

Profit

57.443

76.638

98.777

 

21.36%

28.35%

24.99%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

OPERATIONS & FINANCIAL RESULTS:

 

During the year under report the company has achieved a turnover of Rs. 395.341 Million and earned a net profit of Rs. 121.501 Million after providing depreciation of Rs. 33.719 Million and financial charges of Rs. 3.579 Million. The Directors are hopeful to project better financial results in the forthcoming year.

 

UNSECURED LOAN

 

PARTICULARS

31.03.2014

(Rs. in Million)

31.03.2013

(Rs. in Million)

Long-term Borrowings

 

 

Term loans from others

34.345

42.312

Total

34.345

42.312

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10294214

16/05/2011

40,000,000.00

CANARA BANK

CORPORATE BRANCH ,, S.P.ROAD, SECUNDERABAD, ANDHR
A PRADESH - 500003, INDIA

B15826035

2

10156930

19/01/2011 *

52,900,000.00

DEPARTMENT OF BIOTECHNOLOGY

BLOCK 2, CGO COMPLEX, LODHI ROAD, NEW DELHI, DELH
I - 110003, INDIA

B05885363

 

* Date of charge modification

 

CONTINGENT LIABILITIES:

 

(Rs. in million)

PARTICULARS

31.03.2014

31.03.2013

 

 

 

In respect of Bank Guarantees

0.567

0.567

 

FIXED ASSETS

 

Tangible assets

 

  • Land
  • Buildings
  • Plant and equipment
  • Furniture and fixtures
  • Vehicles
  • Office equipment
  • Computer equipments
  • Other equipments

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.59

UK Pound

1

Rs.92.46

Euro

1

Rs.67.51

 

 

INFORMATION DETAILS

 

Information Gathered by :

DIP

 

 

Analysis Done by :

RAS

 

 

Report Prepared by :

KVT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILITY

1~10

6

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

46

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.